Advanced search×

Aspirin in cardiology--benefits and risks.

L Björklund, M-A Wallander, S Johansson, and E Lesén

Int J Clin Pract 63(3):468-77 (2009) PMID 19222632

To review the current knowledge of the benefits and risks of long-term aspirin therapy for the prevention of cardiovascular disease.

Referenced by 1 articles

DOI: 10.1111/j.1742-1241.2008.01908.x
Version: za2963e q8za3 q8zb5 q8zcf q8zda q8zef q8zfa q8zg4
Buy PDF

Similar articles you may find interesting…

  1. Immunotoxin therapy of hematological malignancies.
    L L Pasqualucci, L L Flenghi, ... B B Falini

    Haematologica 80(6):546-56 (1995) PMID 8647523

    PDF not found
  2. Mesothelin targeted cancer immunotherapy
    Raffit R Hassan and Mitchell M Ho

    Eur J Cancer 44(1):8 (2008) PMID 17945478 PMCID 2265108

    Mesothelin is a tumour differentiation antigen that is normally present on the mesothelial cells lining the pleura, peritoneum and pericardium. It is, however, highly expressed in several human cancers including malignant mesothelioma, pancreatic, ovarian and lung adenocarcinoma. The normal biologic...
    View PDF
  3. Immunotoxins for targeted cancer therapy.
    Robert J RJ Kreitman

    AAPS J 8(3):E532-51 (2006) PMID 17025272

    Immunotoxins are proteins that contain a toxin along with an antibody or growth factor that binds specifically to target cells. Nearly all protein toxins work by enzymatically inhibiting protein synthesis. For the immunotoxin to work, it must bind to and be internalized by the target...
    View PDF